November 11, 2024

Marlabs Recognized as a Rising Star in ISG Provider Lens™ for Specialty Analytics Services in Life Sciences and Healthcare

Bangalore, India  October 14th 2024:  Marlabs LLC, a digital solutions company, announced today that it has been recognized as a “Rising Star” in the ISG Provider Lens™ study for Specialty Analytics services in Life Sciences and Healthcare. This recognition highlights Marlabs’ expertise in delivering tailored analytics and AI-powered solutions that enable Life Sciences and Healthcare organizations enhance patient outcomes, streamline R&D, and improve operational efficiency.

The ISG Provider Lens™ report, known for identifying companies that demonstrate exceptional growth and innovation, awards the Rising Star title to organizations that are on the path to becoming Leaders in the market. Marlabs’ recognition highlights their proven ability to innovate and deliver solutions tailored to the complex demands of Life Sciences and Healthcare, setting it apart in a highly competitive industry.

At the core of Marlabs’ offerings is its Modern Analytics Platform (MAP), a comprehensive data strategy framework that enables the development of custom analytics and AI-driven solutions. These solutions address critical challenges across the entire Life Sciences value chain, from drug discovery and safety monitoring to clinical trials, commercialization, regulatory compliance, and supply chain visibility. By leveraging MAP, Marlabs enables pharmaceutical companies to accelerate their R&D efforts, reduce development costs, and bring safer, more effective treatments to market faster.

According to Manav Deep Sachdeva, Principal Analyst from ISG, “Marlabs uses a combination of deep domain expertise and AI to drive transformation in accelerating drug discovery, optimizing clinical trials, driving patient outcomes, and improving the supply chain for pharmaceutical and medical device clients. Their tailored approach and innovative use of AI make them a key player in the Life Sciences sector.”

Marlabs is also recognized for its innovative use of AI and predictive analytics in drug development and safety monitoring. By applying advanced AI techniques, Marlabs helps pharmaceutical companies conduct targeted research throughout the drug discovery and development process. One of its key strengths is identifying potential safety risks associated with new drugs and treatments, allowing organizations to make informed decisions that prioritize patient safety while advancing drug discovery efforts.

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous post Revisiting the Epic: Must-Watch Ramayana Adaptations That Captured Our Hearts
Next post Saajha Sindoor actress Sangita Ghosh travels to Jaipur for Navratri: The main reason isn’t celebration, but my daughter has started school for the first time